FDA Approves CELECOXIB — Westminster Pharmaceuticals, LLC

Westminster Pharmaceuticals announced the FDA approval of its Abbreviated New Drug Application for celecoxib oral tablets in strengths of 200 mg and 100 mg, signaling a potential new entry in the competitive nonsteroidal anti-inflammatory drug market and driving immediate commercial opportunity for the generic manufacturer.